DAYBROOK MEDICAL PRACTICE
DAYBROOK HEALTH CENTRE, SALOP STREET, DAYBROOK, NOTTINGHAM
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 8 | 12 | 66.7% | |
| HF 4 | 2011 | 12 | 15 | 80.0% | |
| HF 4 | 2012 | 15 | 19 | 78.9% | |
| HF 4 | 2013 | 17 | 20 | 85.0% | |
| HF004 | 2014 | 5 | 5 | 100.0% | |
| HF004 | 2015 | 6 | 7 | 85.7% | |
| HF004 | 2016 | 17 | 18 | 94.4% | |
| HF004 | 2017 | 16 | 17 | 94.1% | |
| HF004 | 2018 | 16 | 16 | 100.0% | |
| HF004 | 2019 | 14 | 16 | 87.5% | |
| HF004 | 2020 | 13 | 13 | 100.0% | |
| HF006 | 2021 | 18 | 18 | 100.0% | |
| HF006 | 2022 | 33 | 35 | 94.3% | |
| HF006 | 2023 | 39 | 39 | 100.0% |
